Epochal sales record of Hanmi's Amodipin.

Just in 2 years of its market launching of Amodipin developed by Hanmi as a modified new amlodipine derivative, it made an epochal record with the total 8.5 million prescriptions, the aggregated sales and the NHI financial saving at the total 30 billion won up to September this year.

Currently about 400 thousand patients are on the medication with Amodipin according to the monthly prescripti...